Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

PROF - Profound Medical Corp.

IEX Last Trade
7.02
-0.035   -0.499%

Share volume: 845
Last Updated: Thu 26 Dec 2024 07:10:45 PM CET
Surgical and Medical Instrument Manufacturing : 1.09%

PREVIOUS CLOSE
CHG
CHG%
$7.06
-0.04
-0.50%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
15%
Profitability 0%
Dept financing 22%
Liquidity 62%
Performance 16%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-0.29%
1 Month
-10.97%
3 Months
-11.08%
6 Months
-21.22%
1 Year
-23.04%
2 Year
-31.97%
Key data
Stock price
$7.02
P/E Ratio 
0.00
DAY RANGE
$7.06 - $7.10
EPS 
$0.00
52 WEEK RANGE
$7.24 - $11.42
52 WEEK CHANGE
-$11.08
MARKET CAP 
224.009 M
YIELD 
N/A
SHARES OUTSTANDING 
24.482 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/31/2024
BETA 
1.05
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$88,910
AVERAGE 30 VOLUME 
$115,317
Company detail
CEO: Arun S. Menawat
Region: US
Website: profoundmedical.com
Employees: 150
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Profound Medical Corp. develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities.

Recent news